Targeted glycan degradation potentiates the anticancer immune response in vivo
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted glycan degradation potentiates the anticancer immune response in vivo
Authors
Keywords
-
Journal
Nature Chemical Biology
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-08-18
DOI
10.1038/s41589-020-0622-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A novel anti-HER2 anthracycline-based antibody-drug conjugate induces adaptive anti-tumor immunity and potentiates PD-1 blockade in breast cancer
- (2019) Lucia D’Amico et al. Journal for ImmunoTherapy of Cancer
- Dual actions of group B Streptococcus capsular sialic acid provide resistance to platelet-mediated antimicrobial killing
- (2019) Satoshi Uchiyama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy
- (2019) Jun Wang et al. NATURE MEDICINE
- Siglec-9 Regulates an Effector Memory CD8+ T-cell Subset That Congregates in the Melanoma Tumor Microenvironment
- (2019) Quentin Haas et al. Cancer Immunology Research
- CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy
- (2019) Amira A. Barkal et al. NATURE
- CRISPR-Cas9 screens identify regulators of antibody–drug conjugate toxicity
- (2019) C. Kimberly Tsui et al. Nature Chemical Biology
- Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1
- (2018) Chia-Wei Li et al. CANCER CELL
- Next generation of immune checkpoint therapy in cancer: new developments and challenges
- (2018) Julian A. Marin-Acevedo et al. Journal of Hematology & Oncology
- Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells
- (2018) Michal A. Stanczak et al. JOURNAL OF CLINICAL INVESTIGATION
- Modulation of Immune Tolerance via Siglec-Sialic Acid Interactions
- (2018) Joyce Lübbers et al. Frontiers in Immunology
- Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma
- (2016) Antoni Ribas et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Precision glycocalyx editing as a strategy for cancer immunotherapy
- (2016) Han Xiao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumor sialylation impedes T cell mediated anti-tumor responses while promoting tumor associated-regulatory T cells
- (2016) Maurizio Perdicchio et al. Oncotarget
- Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
- (2015) Dirk Schadendorf et al. JOURNAL OF CLINICAL ONCOLOGY
- High throughput cross-interaction measures for human IgG1 antibodies correlate with clearance rates in mice
- (2015) Ryan L Kelly et al. mAbs
- Therapeutic Targeting of Siglecs using Antibody- and Glycan-Based Approaches
- (2015) Takashi Angata et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Aldehyde Tag Coupled with HIPS Chemistry Enables the Production of ADCs Conjugated Site-Specifically to Different Antibody Regions with Distinct in Vivo Efficacy and PK Outcomes
- (2014) Penelope M. Drake et al. BIOCONJUGATE CHEMISTRY
- Cancer intelligence acquired (CIA): tumor glycosylation and sialylation codes dismantling antitumor defense
- (2014) Kayluz Frias Boligan et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Interactions between Siglec-7/9 receptors and ligands influence NK cell–dependent tumor immunosurveillance
- (2014) Camilla Jandus et al. JOURNAL OF CLINICAL INVESTIGATION
- Role of Siglec-7 in Apoptosis in Human Platelets
- (2014) Kim Anh Nguyen et al. PLoS One
- Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer
- (2014) Heinz Läubli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hydrazino-Pictet-Spengler Ligation as a Biocompatible Method for the Generation of Stable Protein Conjugates
- (2013) Paresh Agarwal et al. BIOCONJUGATE CHEMISTRY
- Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion
- (2013) Jason E Hudak et al. Nature Chemical Biology
- Catalytic preference of Salmonella typhimurium LT2 sialidase for N -acetylneuraminic acid residues over N -glycolylneuraminic acid residues
- (2013) Akira Minami et al. FEBS Open Bio
- Dendritic Cells: A Spot on Sialic Acid
- (2013) Hélio J. Crespo et al. Frontiers in Immunology
- Siglecs as sensors of self in innate and adaptive immune responses
- (2012) James C. Paulson et al. Annals of the New York Academy of Sciences
- Multifarious roles of sialic acids in immunity
- (2012) Ajit Varki et al. Annals of the New York Academy of Sciences
- A Pictet-Spengler ligation for protein chemical modification
- (2012) P. Agarwal et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions
- (2011) Damya Laoui et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- Sialylation of the Fas Death Receptor by ST6Gal-I Provides Protection against Fas-mediated Apoptosis in Colon Carcinoma Cells
- (2011) Amanda F. Swindall et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Sialylation of 3-Methylcholanthrene-Induced Fibrosarcoma Determines Antitumor Immune Responses during Immunoediting
- (2010) M. Cohen et al. JOURNAL OF IMMUNOLOGY
- Basic and Clinical Immunology of Siglecs
- (2009) Stephan von Gunten et al. Annals of the New York Academy of Sciences
- PD-1 signaling in primary T cells
- (2009) James L. Riley IMMUNOLOGICAL REVIEWS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started